Last reviewed · How we verify
NCT03557450: PETCT
A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone
NA trial testing PET/CT Scan in Normal Subjects in 3 participants. Completed in 25 March 2019.
25 March 2019
Quick facts
| Lead sponsor | University of California, Davis |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 3 |
| Start date | 11 June 2018 |
| Primary completion | 25 March 2019 |
| Estimated completion | 25 March 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- PET/CT Scan
Conditions studied
- Normal Subjects — all drugs for Normal Subjects →
Sponsor
University of California, Davis
Who can join
Adults 20 to 75, any sex, with Normal Subjects. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate if a commonly used medical bone scan, called positron emission tomography/computed tomography (PET/CT) with sodium fluoride can measure bone blood flow to the hip.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03557450
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PET/CT Scan
Trials testing the same drug.
- NCT06863233 — A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer · Phase 1 · recruiting
- NCT04407481 — PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN) · completed
- NCT04074668 — Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance · completed
- NCT04161781 — A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophagea · completed
- NCT02821832 — Using Biomarkers to Predict TB Treatment Duration · Phase 2 · completed
Other recruiting trials for Normal Subjects
Currently open trials in the same condition.
- NCT05412069 — Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI) · NA · recruiting
Other University of California, Davis trials
Trials by the same sponsor.
- NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
- NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
- NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
- NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
- NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03557450 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
- Last refreshed: 30 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03557450.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing